セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/04 | 1,318 | 1,342 | 1,291 | 1,303 | +2 | +0.2% | 54,500 |
| 2024/10/03 | 1,332 | 1,335 | 1,301 | 1,301 | +20 | +1.6% | 43,000 |
| 2024/10/02 | 1,302 | 1,302 | 1,278 | 1,281 | -26 | -2% | 27,400 |
| 2024/10/01 | 1,267 | 1,314 | 1,266 | 1,307 | +57 | +4.6% | 39,600 |
| 2024/09/30 | 1,258 | 1,289 | 1,250 | 1,250 | -55 | -4.2% | 62,800 |
| 2024/09/27 | 1,315 | 1,334 | 1,296 | 1,305 | -3 | -0.2% | 48,900 |
| 2024/09/26 | 1,273 | 1,308 | 1,264 | 1,308 | +36 | +2.8% | 54,300 |
| 2024/09/25 | 1,262 | 1,277 | 1,257 | 1,272 | -2 | -0.2% | 23,700 |
| 2024/09/24 | 1,299 | 1,299 | 1,257 | 1,274 | -15 | -1.2% | 50,100 |
| 2024/09/20 | 1,331 | 1,332 | 1,286 | 1,289 | -43 | -3.2% | 56,400 |
| 2024/09/19 | 1,272 | 1,333 | 1,271 | 1,332 | +77 | +6.1% | 86,400 |
| 2024/09/18 | 1,264 | 1,272 | 1,235 | 1,255 | +18 | +1.5% | 80,300 |
| 2024/09/17 | 1,352 | 1,352 | 1,221 | 1,237 | -117 | -8.6% | 200,000 |
| 2024/09/13 | 1,291 | 1,367 | 1,272 | 1,354 | -27 | -2% | 278,600 |
| 2024/09/12 | 1,384 | 1,425 | 1,380 | 1,381 | +10 | +0.7% | 62,500 |
| 2024/09/11 | 1,393 | 1,419 | 1,355 | 1,371 | -26 | -1.9% | 64,300 |
| 2024/09/10 | 1,418 | 1,437 | 1,393 | 1,397 | -20 | -1.4% | 52,000 |
| 2024/09/09 | 1,401 | 1,432 | 1,401 | 1,417 | +1 | +0.1% | 40,400 |
| 2024/09/06 | 1,475 | 1,475 | 1,407 | 1,416 | -62 | -4.2% | 51,700 |
| 2024/09/05 | 1,482 | 1,519 | 1,460 | 1,478 | -4 | -0.3% | 55,400 |
| 2024/09/04 | 1,460 | 1,510 | 1,456 | 1,482 | -8 | -0.5% | 72,900 |
| 2024/09/03 | 1,450 | 1,515 | 1,450 | 1,490 | +11 | +0.7% | 34,000 |
| 2024/09/02 | 1,492 | 1,501 | 1,464 | 1,479 | -18 | -1.2% | 40,300 |
| 2024/08/30 | 1,535 | 1,540 | 1,480 | 1,497 | -41 | -2.7% | 79,500 |
| 2024/08/29 | 1,533 | 1,542 | 1,490 | 1,538 | +5 | +0.3% | 69,200 |
| 2024/08/28 | 1,525 | 1,544 | 1,511 | 1,533 | -16 | -1% | 48,100 |
| 2024/08/27 | 1,560 | 1,568 | 1,530 | 1,549 | -11 | -0.7% | 61,800 |
| 2024/08/26 | 1,497 | 1,560 | 1,484 | 1,560 | +82 | +5.5% | 105,500 |
| 2024/08/23 | 1,500 | 1,500 | 1,469 | 1,478 | -15 | -1% | 32,500 |
| 2024/08/22 | 1,420 | 1,493 | 1,420 | 1,493 | +71 | +5% | 94,000 |
| 2024/08/21 | 1,437 | 1,472 | 1,412 | 1,422 | -69 | -4.6% | 112,400 |
| 2024/08/20 | 1,424 | 1,494 | 1,424 | 1,491 | +82 | +5.8% | 103,700 |
| 2024/08/19 | 1,420 | 1,461 | 1,400 | 1,409 | -11 | -0.8% | 56,300 |
| 2024/08/16 | 1,397 | 1,420 | 1,388 | 1,420 | +32 | +2.3% | 37,300 |
| 2024/08/15 | 1,391 | 1,412 | 1,363 | 1,388 | -16 | -1.1% | 58,400 |
| 2024/08/14 | 1,445 | 1,445 | 1,388 | 1,404 | -71 | -4.8% | 79,500 |
| 2024/08/13 | 1,370 | 1,480 | 1,365 | 1,475 | +103 | +7.5% | 100,400 |
| 2024/08/09 | 1,364 | 1,386 | 1,339 | 1,372 | +10 | +0.7% | 91,000 |
| 2024/08/08 | 1,290 | 1,376 | 1,281 | 1,362 | +64 | +4.9% | 75,000 |
| 2024/08/07 | 1,292 | 1,345 | 1,278 | 1,298 | -54 | -4% | 168,100 |
| 2024/08/06 | 1,295 | 1,352 | 1,273 | 1,352 | +113 | +9.1% | 90,500 |
| 2024/08/05 | 1,285 | 1,342 | 1,213 | 1,239 | -134 | -9.8% | 203,200 |
| 2024/08/02 | 1,460 | 1,460 | 1,373 | 1,373 | -117 | -7.9% | 142,600 |
| 2024/08/01 | 1,521 | 1,556 | 1,490 | 1,490 | -67 | -4.3% | 102,800 |
| 2024/07/31 | 1,558 | 1,559 | 1,465 | 1,557 | -19 | -1.2% | 160,000 |
| 2024/07/30 | 1,560 | 1,588 | 1,516 | 1,576 | +16 | +1% | 573,700 |
| 2024/07/29 | 1,546 | 1,560 | 1,505 | 1,560 | +43 | +2.8% | 106,100 |
| 2024/07/26 | 1,469 | 1,540 | 1,469 | 1,517 | +40 | +2.7% | 122,800 |
| 2024/07/25 | 1,475 | 1,509 | 1,450 | 1,477 | -16 | -1.1% | 140,200 |
| 2024/07/24 | 1,510 | 1,579 | 1,491 | 1,493 | -17 | -1.1% | 200,400 |
151～
200
件表示中 / 1357件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 63,700円 | - | - | 0.78% | 49.50倍 | 2.11倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| オンコリス | 52,500円 | +3771.0% | - | 0.00% | - | 4.76倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| 大幸薬品 | 25,100円 | +0.1% | -70.9% | 0.00% | 41.97倍 | 1.58倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ラクオリア | 55,500円 | +25.1% | - | 0.00% | - | 2.44倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| ステラファーマ | 33,200円 | +4.8% | - | 0.00% | - | 3.53倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム
